» Articles » PMID: 20524084

Primary Esophageal CD30-positive ALK-positive Anaplastic Large Cell Lymphoma: a Case Report and Literature Review

Overview
Publisher Springer
Date 2010 Jun 5
PMID 20524084
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To introduce a case of primary esophageal CD30-positive ALK-positive anaplastic large cell lymphoma (ALCL) and discuss its diagnosis and treatment.

Methods: Esophagectomy was done for a 37-year-old male with a submucosal lesion after a frozen section failed to give a definite diagnosis. Samples were sent for hematoxylin-eosin staining and immunohistochemical analysis. Six cycles of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy were given and the patient was followed up.

Results: The operation was uneventful. Postoperative pathologic and immunohistochemical examination yielded a diagnosis of primary CD30-positive and ALK-positive ALCL of the esophagus. The patient was in complete remission at the 14-month follow-up.

Conclusions: ALCL of the esophagus should be considered in the differential diagnosis of esophageal submucosal lesions. Biopsy through either esophagoscopy or surgical exploration, chemotherapy, and radiotherapy can be chosen for long-term survival.

Citing Articles

Treatment of primary esophageal lymphomas: A review.

El Khoury J, Daou R, Kim N, Bou Eid J, Imber B, Yahalom J Front Oncol. 2025; 15:1475153.

PMID: 39980557 PMC: 11839416. DOI: 10.3389/fonc.2025.1475153.


Primary Esophageal Lymphoma: A Histopathological Experience from Two Tertiary Hospitals, Western Saudi Arabia.

Al-Maghrabi J, Al-Maghrabi S Gastroenterol Res Pract. 2023; 2023:7302344.

PMID: 36756091 PMC: 9902162. DOI: 10.1155/2023/7302344.


Primary Esophageal Lymphoma: A Rare Entity.

Sachdeva S, Jain A, Dalal A, Puri A GE Port J Gastroenterol. 2022; 29(5):366-368.

PMID: 36159195 PMC: 9485927. DOI: 10.1159/000515840.


Primary esophageal non-Hodgkin's lymphoma: demographics, clinical characteristics, histopathologic types, and survival in 179 patients from the SEER program and systematic review of the literature.

Quiroga-Centeno A, Bautista-Parada I, Tapias L, Gomez-Ochoa S Esophagus. 2021; 18(4):734-742.

PMID: 33880688 DOI: 10.1007/s10388-021-00842-0.


Successful treatment of post chemotherapy esophageal cicatricial atresia in a pediatric patient with anaplastic large cell lymphoma through minimally invasive esophagectomy: a case report.

Hozaka Y, Sasaki K, Nishikawa T, Onishi S, Noda M, Tsuruda Y Surg Case Rep. 2021; 7(1):41.

PMID: 33544280 PMC: 7865044. DOI: 10.1186/s40792-021-01108-8.


References
1.
STEIN H, Foss H, Durkop H, Marafioti T, Delsol G, Pulford K . CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000; 96(12):3681-95. View

2.
Ross C, Hanson C, Schnitzer B . CD30 (Ki-1)-positive, anaplastic large cell lymphoma mimicking gastrointestinal carcinoma. Cancer. 1992; 70(10):2517-23. DOI: 10.1002/1097-0142(19921115)70:10<2517::aid-cncr2820701021>3.0.co;2-u. View

3.
Pearson J . Primary Ki-1 (CD 30)-positive, large cell, anaplastic lymphoma of the esophagus. Cancer. 1991; 68(2):418-21. DOI: 10.1002/1097-0142(19910715)68:2<418::aid-cncr2820680234>3.0.co;2-1. View

4.
Doki T, Hamada S, Murayama H, Suenaga H, Sannohe Y . Primary malignant lymphoma of the esophagus. A case report. Endoscopy. 1984; 16(5):189-92. DOI: 10.1055/s-2007-1018579. View

5.
Ann Thompson M, Stumph J, Henrickson S, Rosenwald A, Wang Q, Olson S . Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. Hum Pathol. 2005; 36(5):494-504. DOI: 10.1016/j.humpath.2005.03.004. View